Price to Cash-Flow of WuXi AppTec (H)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Cash-Flow analysis of WuXi AppTec (H)


 Price HKD  109.50
 Cahs-flow per share HKD  1.73
 Capitalization (mn) HKD  15,950
 Free Cash-flow (mn) HKD  296
 P/CF ratio 63.40
 WuXi AppTec (H) dividend
 WuXi AppTec (H) Price to book Value
 WuXi AppTec (H) Price to earnings
 WuXi AppTec (H) Return on Equity

WuXi AppTec (H) is a Health Care industry firm, which concentrates their activity in the Pharmaceuticals and Biotechnology sector. WuXi AppTec (H) headquarters are in China, where the firm is listed.

At the time of this analysis, WuXi AppTec (H) stocks were trading at a price of 109.50 HKD after hiking a 58.90% last twelve months.

According to the chart displayed below, WuXi AppTec (H) Price to Cash-flow Ratio is 63.40, bigger than the amount offered by both firms from China and fromPharmaceuticals and Biotechnology sector. This high P/CF might be a sign of a overvalued company, but also a healthy sign because the market expects growing cash-inflows (or a reduction in cash-outflows) in the future. Therefore, it is necessary to study WuXi AppTec (H) financial situation to reach a conclussion.

Finally, you could draw a comparisson WuXi AppTec (H) P/CF with other Pharmaceuticals and Biotechnology companies or firms from China.

WuXi AppTec (H) price to earnings

Next companies

WuXi Biologics (P Chip). China. Health Care.

Wyndham Hotels & Resorts. USA. Consumer Services.

Wynn Macau Ltd.. Hong-Kong. Consumer Services.

Wynn Resorts. USA. Consumer Services.

Xcel Energy. USA. Utilities.

Xero. Australia. Technology.

Previous companies

WPP. UK. Consumer Services.

WP Carey Inc. USA. Financials.

Worley Parsons. Australia. Oil and Gas.

Worldline. France. Industrials.

Workday. USA. Technology.

Woori Financial Group. Korea. Financials.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.